Literature DB >> 21793861

Vagal stimulation promotes atrial electrical remodeling induced by rapid atrial pacing in dogs: evidence of a noncholinergic effect.

Donghui Yang1, Yutao Xi, Tomohiko Ai, Geru Wu, Junping Sun, Mehdi Razavi, Scott Delapasse, Mossaib Shurail, Lianjun Gao, Nilesh Mathuria, Macarthur Elayda, Jie Cheng.   

Abstract

BACKGROUND: Atrial electrical remodeling (AER) is one of the mechanisms by which atrial fibrillation (AF) begets AF. It is known that vagal activity increases the propensity for AF. However, vagal effects on AER have not been fully investigated.
METHODS: Adult mongrel dogs were divided in four groups: group I, rapid atria pacing (RAP); group II, RAP plus vagal nerve stimulation (VNS); group III, RAP and VNS with atropine (0.2 mg/kg/h, intravenous), and group IV, group III plus vasoactive intestinal polypeptide (VIP) antagonist ([D-p-Cl-Phe(6), Leu(17)]-VIP, 0.125 μg/kg/h). VNS was performed bilaterally through vagosympathetic trunks to achieve second-degree AV block or sinus rate slowing of >30 beats per minute. Atrial effective refractory periods (AERPs) were determined in the coronary sinus and right atrial appendage every hour at drive cycle lengths (DCLs) 350 ms, 300 ms, and 250 ms.
RESULTS: During 5 hours RAP with or without VNS, AERP shortened progressively from baseline at both pacing sites and at all DCLs (P < 0.01). Furthermore, RAP-induced AERP shortening was more pronounced with VNS (P < 0.01). With atropine, the AERP shortening during VNS was blunted (P < 0.01), but was still significantly more pronounced than that in group I (P < 0.05). However, VNS effect on AERP shortening was eliminated completely with the combination of atropine and VIP antagonist (P = 0.15 vs group I).
CONCLUSION: Increased vagal activity promotes RAP-induced AER, which could not be totally accounted for by cholinergic effect but could be blocked by the combination of atropine and VIP antagonist. Vagally released VIP may have important role in the vagal promotion of AER. ©2011, The Authors. Journal compilation ©2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21793861     DOI: 10.1111/j.1540-8159.2011.03133.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

Review 1.  Dysfunction of the autonomic nervous system in atrial fibrillation.

Authors:  Yutao Xi; Jie Cheng
Journal:  J Thorac Dis       Date:  2015-02       Impact factor: 2.895

2.  Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation.

Authors:  Yutao Xi; Zhi-Yang James Chao; Wen Yan; Shahrzad Abbasi; Xiaomeng Yin; Nilesh Mathuria; Mehul Patel; Christopher Fan; Junping Sun; Geru Wu; Suwei Wang; MacArthur Elayda; Lianjun Gao; Xander H T Wehrens; Shien-Fong Lin; Jie Cheng
Journal:  Heart Rhythm       Date:  2015-03-05       Impact factor: 6.343

3.  Inhibition of atrial fibrillation by low-level vagus nerve stimulation: the role of the nitric oxide signaling pathway.

Authors:  Stavros Stavrakis; Benjamin J Scherlag; Youqi Fan; Yu Liu; Jun Mao; Vandana Varma; Ralph Lazzara; Sunny S Po
Journal:  J Interv Card Electrophysiol       Date:  2012-11-20       Impact factor: 1.900

4.  Electrical PR Interval Variation Predicts New Occurrence of Atrial Fibrillation in Patients With Frequent Premature Atrial Contractions.

Authors:  Kwang Jin Chun; Jin Kyung Hwang; Seung-Jung Park; Young Keun On; June Soo Kim; Kyoung-Min Park
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Assessment of Atrial Conduction Times in Patients with Newly Diagnosed Parkinson's Disease.

Authors:  Yiğit Çanga; Ayşe Emre; Gülbün Asuman Yüksel; Mehmet Baran Karataş; Nizamettin Selçuk Yelgeç; Ufuk Gürkan; Ali Nazmi Çalık; Hülya Tireli; Sait Terzi
Journal:  Parkinsons Dis       Date:  2018-07-16

6.  Higher heart rate variability as a predictor of atrial fibrillation in patients with hypertension.

Authors:  San Ha Kim; Kyoung Ree Lim; Jeong-Hun Seo; Dong Ryeol Ryu; Bong-Ki Lee; Byung-Ryul Cho; Kwang Jin Chun
Journal:  Sci Rep       Date:  2022-03-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.